CasNo.188559-29-7,[4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone,[4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone(188559-29-7) Suppliers

0	Negotiable

Min.Order :0
Purity: 98%

Keywords

188559-29-7 [4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxope FT-0663379

Quick Details

Appearance:contact us for more details about [4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS:188559-29-7
Application:Chemicals, pharmaceutical research, pharmaceutical intermediates, reagents
PackAge:Glass bottle in aluminum foil bag, from mg scale to kg scale
ProductionCapacity:
Storage:Seal dark and dry place or contact us for more details
Transportation:World wide Courier Service or Air to save your time

Superiority:

FINETECH INDUSTRY LIMITED is a LONDON based CRO company providing drug discovery & development services to worldwide clients. FINETECH INDUSTRY LIMITED supplies the [4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS:188559-29-7 with the most competitive price and the best quality. We can offer efficient service and the best package.Welcome the enquiries & orders around the world. If you have more question or need COA,MSDS,test spectra of [4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS:188559-29-7 please feel easy to contact with us.

Details:

Catalog No.:FT-0663379, Product Name:[4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS No.:188559-29-7, MF:C38H40N2O5, FW:604.73. If you need this product or more information please feel easy to contact with FINETECH INDUSTRY LIMITED.